Sergey A Belukhin

1PUBLICATIONS
11CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Feb 16, 2022
Changes in the concentration of EGFR-mutated plasma DNA in the first hours of targeted therapy allow the prediction of tumor response in patients with EGFR-driven lung cancer.

Fedor V Moiseyenko, Ekaterina S Kuligina, Albina S Zhabina

Pageof 1

Frequent Collaborators

1 joint publications

Fedor V Moiseyenko

1 joint publications

Ekaterina S Kuligina

1 joint publications

Albina S Zhabina

1 joint publications

Tatiana A Laidus

1 joint publications

Aleksandr S Martianov

1 joint publications

Tatyana N Sokolova

1 joint publications

Maxim M Kholmatov

1 joint publications

Ekaterina O Stepanova

1 joint publications

Nikita M Volkov

1 joint publications

Grigoriy A Yanus

Frequent Collaborators

1 joint publications

Fedor V Moiseyenko

1 joint publications

Ekaterina S Kuligina

1 joint publications

Albina S Zhabina

1 joint publications

Tatiana A Laidus

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
08:52

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on : Nov 22, 2021

4.2K
See more related videos

Top Related Videos

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
08:52

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on : Nov 22, 2021

4.2K
See more related videos